Görlinger Klaus, Fries Dietmar, Dirkmann Daniel, Weber Christian F, Hanke Alexander A, Schöchl Herbert
Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen, Germany.
Transfus Med Hemother. 2012 Apr;39(2):104-113. doi: 10.1159/000337186. Epub 2012 Mar 8.
Massive bleeding and transfusion of packed red blood cells (PRBC), fresh frozen plasma (FFP) and platelets are associated with increased morbidity, mortality and costs. PATIENTS AND METHODS: We analysed the transfusion requirements after implementation of point-of-care (POC) coagulation management algorithms based on early, calculated, goal-directed therapy with fibrinogen concentrate and prothrombin complex concentrate (PCC) in different perioperative settings (trauma surgery, visceral and transplant surgery (VTS), cardiovascular surgery (CVS) and general and surgical intensive care medicine) at 3 different hospitals (AUVA Trauma Centre Salzburg, University Hospital Innsbruck and University Hospital Essen) in 2 different countries (Austria and Germany). RESULTS: In all institutions, the implementation of POC coagulation management algorithms was associated with a reduction in the transfusion requirements for FFP by about 90% (Salzburg 94%, Innsbruck 88% and Essen 93%). Furthermore, PRBC transfusion was reduced by 8.4-62%. The incidence of intraoperative massive transfusion (≥10 U PRBC) could be more than halved in VTS and CVS (2.56 vs. 0.88%; p < 0.0001 and 2.50 vs. 1.06%; p = 0.0007, respectively). Platelet transfusion could be reduced by 21-72%, except in CVS where it increased by 115% due to a 5-fold increase in patients with dual antiplatelet therapy (2.7 vs. 13.7%; p < 0.0001). CONCLUSIONS: The implementation of perioperative POC coagulation management algorithms based on early, calculated, goal-directed therapy with fibrinogen concentrate and PCC is associated with a reduction in the transfusion requirements for FFP, PRBC and platelets as well as with a reduced incidence of massive transfusion. Thus, the limited blood resources can be used more efficiently.
大量出血以及输注浓缩红细胞(PRBC)、新鲜冰冻血浆(FFP)和血小板与发病率、死亡率增加及成本上升相关。
我们分析了在奥地利和德国的3家不同医院(萨尔茨堡AUVA创伤中心、因斯布鲁克大学医院和埃森大学医院)的不同围手术期环境(创伤手术、内脏和移植手术(VTS)、心血管手术(CVS)以及普通外科和外科重症监护医学)中,基于早期计算的目标导向治疗并使用纤维蛋白原浓缩物和凝血酶原复合物浓缩物(PCC)实施即时检验(POC)凝血管理算法后的输血需求。
在所有机构中,POC凝血管理算法的实施与FFP输血需求减少约90%相关(萨尔茨堡94%、因斯布鲁克88%、埃森93%)。此外,PRBC输血减少了8.4% - 62%。在VTS和CVS中,术中大量输血(≥10单位PRBC)的发生率可降低一半以上(分别为2.56%对0.88%;p < 0.0001和2.50%对1.06%;p = 0.0007)。血小板输血可减少21% - 72%,CVS除外,在CVS中由于双联抗血小板治疗患者增加5倍,血小板输血增加了115%(2.7%对13.7%;p < 0.0001)。
基于早期计算的目标导向治疗并使用纤维蛋白原浓缩物和PCC实施围手术期POC凝血管理算法与FFP、PRBC和血小板的输血需求减少以及大量输血发生率降低相关。因此,有限的血液资源可以得到更有效的利用。